135 related articles for article (PubMed ID: 33786468)
1. Development of a Japanese Version of the Daily Record of Severity of Problems for Diagnosing Premenstrual Syndrome.
Ikeda Y; Egawa M; Hiyoshi K; Ueno T; Ueda K; Becker CB; Takahashi Y; Nakayama T; Mandai M
Womens Health Rep (New Rochelle); 2020; 1(1):11-16. PubMed ID: 33786468
[No Abstract] [Full Text] [Related]
2. The Japanese Version of the Daily Record of Severity of Problems for Premenstrual Symptoms: Reliability and Validity Among the General Japanese Population.
Takeda T; Yoshimi K; Kai S; Inoue F
Int J Womens Health; 2024; 16():299-308. PubMed ID: 38435757
[TBL] [Abstract][Full Text] [Related]
3. The reliability and validity of the Japanese version of the Daily Record of Severity of Problems (J-DRSP) and Development of a Short-Form version (J-DRSP (SF)) to assess symptoms of premenstrual syndrome among Japanese women.
Ikeda Y; Egawa M; Okamoto K; Mandai M; Takahashi Y; Nakayama T
Biopsychosoc Med; 2021 Mar; 15(1):6. PubMed ID: 33736660
[TBL] [Abstract][Full Text] [Related]
4. Psychometric Testing of the Japanese Version of the Daily Record of Severity of Problems Among Japanese Women.
Takeda T; Kai S; Yoshimi K
Int J Womens Health; 2021; 13():361-367. PubMed ID: 33833588
[TBL] [Abstract][Full Text] [Related]
5. Premenstrual Syndrome Diagnosis: A Comparative Study between the Daily Record of Severity of Problems (DRSP) and the Premenstrual Symptoms Screening Tool (PSST).
Henz A; Ferreira CF; Oderich CL; Gallon CW; Castro JRS; Conzatti M; Fleck MPA; Wender MCO
Rev Bras Ginecol Obstet; 2018 Jan; 40(1):20-25. PubMed ID: 29132173
[TBL] [Abstract][Full Text] [Related]
6. A lecithin phosphatidylserine and phosphatidic acid complex (PAS) reduces symptoms of the premenstrual syndrome (PMS): Results of a randomized, placebo-controlled, double-blind clinical trial.
Schmidt K; Weber N; Steiner M; Meyer N; Dubberke A; Rutenberg D; Hellhammer J
Clin Nutr ESPEN; 2018 Apr; 24():22-30. PubMed ID: 29576358
[TBL] [Abstract][Full Text] [Related]
7. Differences in symptom scores and health outcomes in premenstrual syndrome.
Borenstein JE; Dean BB; Leifke E; Korner P; Yonkers KA
J Womens Health (Larchmt); 2007 Oct; 16(8):1139-44. PubMed ID: 17937566
[TBL] [Abstract][Full Text] [Related]
8. Explorative evaluation of the impact of severe premenstrual disorders on work absenteeism and productivity.
Heinemann LA; Minh TD; Filonenko A; Uhl-Hochgräber K
Womens Health Issues; 2010; 20(1):58-65. PubMed ID: 20123176
[TBL] [Abstract][Full Text] [Related]
9. Weekly luteal-phase dosing with enteric-coated fluoxetine 90 mg in premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled clinical trial.
Miner C; Brown E; McCray S; Gonzales J; Wohlreich M
Clin Ther; 2002 Mar; 24(3):417-33. PubMed ID: 11952025
[TBL] [Abstract][Full Text] [Related]
10. Survey of premenstrual symptom severity and impairment in Korean adolescents: premenstrual dysphoric disorder, subthreshold premenstrual dysphoric disorder and premenstrual syndrome.
Yang J; Joe SH; Lee MS; Kim SH; Jung IK
Asia Pac Psychiatry; 2014 Jun; 6(2):135-44. PubMed ID: 23857722
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of premenstrual syndrome and premenstrual dysphoric disorder in a population-based sample in China.
Qiao M; Zhang H; Liu H; Luo S; Wang T; Zhang J; Ji L
Eur J Obstet Gynecol Reprod Biol; 2012 May; 162(1):83-6. PubMed ID: 22377229
[TBL] [Abstract][Full Text] [Related]
12. Chinese version of Daily Record of Severity of Problems: reliability and validity.
Wu L; He Z; Zhao H; Ma D; Zhang S; Deng H; Liang T
J Adv Nurs; 2013 Feb; 69(2):449-56. PubMed ID: 22737971
[TBL] [Abstract][Full Text] [Related]
13. Ulipristal Acetate for Treatment of Premenstrual Dysphoric Disorder: A Proof-of-Concept Randomized Controlled Trial.
Comasco E; Kopp Kallner H; Bixo M; Hirschberg AL; Nyback S; de Grauw H; Epperson CN; Sundström-Poromaa I
Am J Psychiatry; 2021 Mar; 178(3):256-265. PubMed ID: 33297719
[TBL] [Abstract][Full Text] [Related]
14. Using the daily record of severity of problems as a screening instrument for premenstrual syndrome.
Borenstein JE; Dean BB; Yonkers KA; Endicott J
Obstet Gynecol; 2007 May; 109(5):1068-75. PubMed ID: 17470584
[TBL] [Abstract][Full Text] [Related]
15. A Pilot Randomized Treatment-Controlled Trial Comparing Vitamin B6 with Broad-Spectrum Micronutrients for Premenstrual Syndrome.
Retallick-Brown H; Blampied N; Rucklidge JJ
J Altern Complement Med; 2020 Feb; 26(2):88-97. PubMed ID: 31928364
[No Abstract] [Full Text] [Related]
16. Explorative evaluation of the impact of premenstrual disorder on daily functioning and quality of life.
Heinemann LA; Do Minh T; Filonenko A; Uhl-Hochgräber K
Patient; 2010 Jun; 3(2):125-32. PubMed ID: 22273361
[TBL] [Abstract][Full Text] [Related]
17. The Concentration of 8-Hydroxy-2'-Deoxyguanosine in Plasma During the Menstrual Cycle in Young Japanese Women.
Yama K; Shinbo H; Fujikane Y; Mikami C; Machida M; Miura J
Womens Health Rep (New Rochelle); 2022; 3(1):267-273. PubMed ID: 35262065
[No Abstract] [Full Text] [Related]
18. Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder.
Freeman EW; Kroll R; Rapkin A; Pearlstein T; Brown C; Parsey K; Zhang P; Patel H; Foegh M;
J Womens Health Gend Based Med; 2001; 10(6):561-9. PubMed ID: 11559453
[TBL] [Abstract][Full Text] [Related]
19. Correction to: The reliability and validity of the Japanese version of the daily record of severity of problems (J-DRSP) and development of a short-form version (J-DRSP (SF)) to assess symptoms of premenstrual syndrome among Japanese women.
Ikeda Y; Egawa M; Okamoto K; Mandai M; Takahashi Y; Nakayama T
Biopsychosoc Med; 2021 Dec; 15(1):27. PubMed ID: 34972535
[No Abstract] [Full Text] [Related]
20. Daily Record of Severity of Problems (DRSP): reliability and validity.
Endicott J; Nee J; Harrison W
Arch Womens Ment Health; 2006 Jan; 9(1):41-9. PubMed ID: 16172836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
